Share
Bookmark
PrintNews
Shedding Light On The Evolution Of The 2009 Pandemic Influenza A(H1N1) Virus In Japan
Analysis of mutations of the 2009 pandemic influenza A(H1N1) virus by researchers at the RIKEN Omics Science Center (OSC) has revealed major genetic differences between the virus in its early phase of infection in Japan and in its peak phase... . ...>Read More...
Shedding Light On The Evolution Of The 2009 Pandemic Influenza A(H1N1) Virus In Japan
Analysis of mutations of the 2009 pandemic influenza A(H1N1) virus by researchers at the RIKEN Omics Science Center (OSC) has revealed major genetic differences between the virus in its early phase of infection in Japan and in its peak phase... . ...>Read More...
Helping Families Let Go
While working as a critical care nurse, Assistant Professor Debra Wiegand witnessed again and again how patients' families struggled with the overwhelming crisis of deciding if and when to withhold and withdraw life-sustaining treatment from patients with life-threatening illness or injuries... . ...>Read More...
Stemming HIV/AIDS Among Nurses In Sub-Saharan Africa
Nowhere in the world has the AIDS/HIV pandemic cut a greater swath of devastation than in sub-Saharan Africa, where two-thirds of all people infected with the virus reside. As Barbara Smith, PhD, RN, FAAN, discovered firsthand, no segment of society there has been left unscathed... . ...>Read More...
Stemming HIV/AIDS Among Nurses In Sub-Saharan Africa
Nowhere in the world has the AIDS/HIV pandemic cut a greater swath of devastation than in sub-Saharan Africa, where two-thirds of all people infected with the virus reside. As Barbara Smith, PhD, RN, FAAN, discovered firsthand, no segment of society there has been left unscathed... . ...>Read More...
Avastin Vs Lucentis: A Cheaper Drug To Treat Blindness Revealed
Simply stated, macular degeneration is the most common cause of age related blindness. This week, it seems that there may be a cheaper medical alternative that previously thought as a new report states that both brand names Lucentis and Avastin are equally affective. Avastin costs about $50 USD a dose, while Lucentis runs a patient about $2,000 USD. Dr... . ...>Read More...
Avastin Vs Lucentis: A Cheaper Drug To Treat Blindness Revealed
Simply stated, macular degeneration is the most common cause of age related blindness. This week, it seems that there may be a cheaper medical alternative that previously thought as a new report states that both brand names Lucentis and Avastin are equally affective. Avastin costs about $50 USD a dose, while Lucentis runs a patient about $2,000 USD. Dr... . ...>Read More...
Gene Therapy Shows Promise Against Age-Related Macular Degeneration
A gene therapy approach using a protein called CD59, or protectin, shows promise in slowing the signs of age-related macular degeneration (AMD), according to a new in vivo study by researchers at Tufts University School of Medicine... . ...>Read More...
Gene Therapy Shows Promise Against Age-Related Macular Degeneration
A gene therapy approach using a protein called CD59, or protectin, shows promise in slowing the signs of age-related macular degeneration (AMD), according to a new in vivo study by researchers at Tufts University School of Medicine... . ...>Read More...
Bioptigen Unveils Image Analysis Software
Bioptigen Inc., a medical device company whose innovative ophthalmic imaging technologies produce highly resolved images for researchers and clinicians, has released a new software package, InVivoVue™Miner. InVivoVueMiner automates analysis of retinal layers of mouse models acquired in vivo with Bioptigen's spectral domain optical coherence tomography imaging systems... . ...>Read More...
Recent Medical Tips
Become a Member
'CareUltimate.com' is a non-profitable, social welfare initiative of Sudha Foundation. Utilize this '1st of its kind' opportunity to become a member of the portal and start collaborating with our panel of doctors to have your medical-related queries clarified!